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ABSTRACT
Ficus deltoidea is one of the common medicinal plants used in Malaysia. This epiphytic plant, from the Moraceae family 
has been claimed to have antidiabetic property. However, scientific evidence to confirm its efficacy is still lacking. The 
present study was undertaken to evaluate the effect of ethanolic extract of F. deltoidea on glucose level in normal rats 
at different prandial state. The results showed that, all doses of ethanolic extract of F. deltoidea reduced fasting blood 
glucose particularly after 6 h of administration. Interestingly, the extract did not produce severe hypoglycemia as shown 
by its comparable effect with metformin. Likewise, postprandial hyperglycemia was also significantly reduced particularly 
after 4 and 6 h of administration. Furthermore, extract was used at a dose of 1000 mg/kg b.w., reduced postprandial 
hyperglycemia similar to metformin. This suggests that postprandial antihyperglycemic mechanism of this extract is 
mediated through enhancement of glucose uptake into muscle cells and reduction of hepatic gluconeogenesis. Glucose 
tolerance activity was also significantly improved in the presence of ethanolic extract of F. deltoidea. From this study, it 
is suggested that ethanolic extract of F. deltoidea reduced postprandial hyperglycemia and improves glucose tolerance 
activity in normal rats. 
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ABSTRAK
Ficus deltoidea merupakan salah satu tumbuhan ubatan yang lazim di Malaysia. Pokok epifit ini, daripada keluarga 
Moraceae dipercayai mempunyai sifat antidiabetik. Walau bagaimanapun, bukti saintifik untuk mengesahkan 
keberkesanannya masih kurang. Kajian ini dijalankan untuk menilai kesan ekstrak ethanol F. deltoidea terhadap aras 
glukosa di dalam tikus normal pada keadaan prandial yang berbeza. Keputusan menunjukkan bahawa, kesemua dos 
ekstrak menurunkan flukosa darah puasa terutamanya selepas 6 jam pengambilan. Yang menariknya, ekstrak ini tidak 
menyebabkan hipoglisemia terus sebagaimana yang ditunjukkan oleh kesannya yang sebanding dengan metformin. 
Begitu juga, hiperglisemia posprandial turut diturunkan secara signifikan terutamanya 4 dan 6 jam selepas pengambilan. 
Tambahan lagi, ekstrak digunakan pada dos 1000 mg/kg b.w. telah menunjukkan penuruan hiperglisemia posprandial 
sama seperti metformin. Ini mencadangkan bahawa mekanisme antihiperglisemia posprandial ekstrak ini  diperantarakan 
melalui peningkatan pengambilan glukosa ke dalam sel otot dan penurunan glukoneogenesis hati. Aktviti toleransi glukosa 
juga diperbaiki secara signifikan dengan kehadiran ekstrak ethanol F. deltoidea. Daripada kajian ini, dicadangkan 
bahawa ekstrak ethanol F. deltoidea menurunkan hipeerglisemia posprandial dan memperbaiki aktiviti toleransi flukosa 
di dalam tikus normal.
Kata kunci: Aktiviti toleransi glukosa; antihiperglisemia posprandial; F. deltoidea
INTRODUCTION
Diabetes mellitus is a metabolic disease characterized by 
persistent hyperglycemia in fasting and/or postprandial 
state with disturbances in carbohydrate, fat and protein 
metabolism resulting from defects of insulin secretion or 
insulin action or combination of these two factors (WHO 
1999; Zanatta et al. 2007). It remains a major global health 
problem in most countries even though there are plenty of 
antidiabetic agents available in the market. In addition, it 
is the first leading causes of death in developed country 
and has been an epidemic in many developing countries 
including Malaysia (Ooyub et al. 2004). Globally, the 
prevalence of diabetes for all groups of age was estimated 
to be 2.8% in 2000 and this number is estimated to rise 
by 4.4% in 2030. Recent estimation indicates that there 
were 171 diabetes sufferers in the world in 2000 and this 
is projected to increase to 366 million by 2030 (Wild et al. 
2004). In Malaysia, prevalence of diabetes mellitus has 
steadily increased with an estimated number of people 
with diabetes was 0.65% in 1960 and 2% in 1982 (Ooyub 
et al. 2004). The National Health and Morbidity Survey 
(NHMS) I, II and III which was conducted in 1986, 1996 
and 2006 reported the prevalence of diabetes were 6.3%, 
8.3% and 14.9%, respectively in subjects above 30 years 
(Zanariah et al. 2006). 
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 Currently, treatment of diabetes mellitus involves 
exercise, diet therapy, insulin therapy and oral 
antidiabetic agents such as sulphonylureas, biguanides, 
thiazolidinediones and α-glucosidase inhibitor (Kimmel & 
Inzucchi 2005; Li et al. 2005). Despite of their effectiveness 
in reducing hyperglycemia, the use of these drugs are 
associated with non-desirable side effects. For instant, 
sulphonylureas treatment is associated with hypoglycemia 
and weight gain (Kimmel & Inzucchi 2005); α-glucosidase 
inhibitor causes hepatotoxicity and gastrointestinal adverse 
reaction (Andrade et al. 1998; Coniff & Krol 1997). 
Therefore, searching for new effective antihyperglycemic 
agents with minimal side effects should be continued. 
Plants have been widely used for searching of new 
antidiabetic agents as it is proposed to be safe and have 
minimal side effects (Li et al. 2005). 
 F. deltoidea, from the Moraceae family is commonly 
used as a medicinal plant in Malaysia (Mat-Salleh & Latif 
2002). This plant which is a native to Southeast Asia and 
Philiphines (Forest et al. 2003) are also used to treat other 
kind of ailments. For example, the roots and leaves have 
been used to relieve headache and fever (Mat-Salleh & 
Latif 2002). The fruits are chewed to relieve toothache and 
decoction of the whole plants was used as herbal drink by 
women after birth to strengthen the uterus (Sulaiman et 
al. 2008). Recent study on aqueous extract of F. deltoidea 
indicated the antinociceptive activity (Sulaiman et al. 2008) 
and antiulcerogenic activity against ethanol-induced gastric 
mucosal injury in rats (Siti Fatimah Zahra et al. 2009). In 
addition, Hakiman and Maziah (2009) have found that 
aqueous extract of different F. deltoidea accessions possess 
non enzymatic and enzymatic antioxidant activities. Study 
on chemical constituents of F. deltoidea by Din et al. (2002) 
reported the absence of alkaloid, triterpine and saponin 
in F. deltoidea leaves. However, Zunoliza et al. (2009) 
has reported that F. deltoidea var. angustifolia contains 
polyphenols, flavonoids and tannins. They also found that 
methanolic extract of F. deltoidea var. angustifolia has 
higher metabolites content than aqueous extract. 
 Based on ethnobotanical approaches, F. deltoidea 
has been claimed to possess antidiabetic properties, and 
it has been used traditionally as a treatment for diabetes. 
Nevertheless, scientific evidence to confirm its efficacy and 
its possible mode of action is still lacking. Therefore, the 
present study was undertaken to evaluate the potential of 
ethanolic extract of F. deltoidea to reduce blood glucose 
level in normal rats at different prandial states.
MATERIALS AND METHODS
CHEMICALS 
Ethanol and diethylether were purchased from Merck 
(Darmstadt, Germany). Carboxymethylcellulose (CMC), 
metformin and glucose were purchased from Sigma 
Chemical Co. (St. Louis, USA). 
PLANT MATERIALS AND ExTRACTION
F. deltoidea plants were collected from Sungai Tengi 
Selatan, Selangor, Malaysia. The specimen was identified by 
taxonomist from Biodiversity Unit, Institute of Biological 
Science, Universiti Putra Malaysia and was deposited at the 
herbarium of the above institute (SK1467/07). The leaves 
of F. deltoidea were dried at 45°C and grounded into a 
fine powder. Ethanolic extract was prepared by soaking 
the sample powder in 70% ethanol for 3 days (100 g/L) at 
room temperature by changing solvent daily. The combined 
suspension was filtered using whatman filter paper No. 54 
and evaporated to dryness under reduced pressure. 
ANIMALS
Adult Sprague Dawley rats (200-250 gram) which were 
used in the study were breed in house at Animal House 
of Malaysian Nuclear Agency. Animals were housed in 
polycarbonate cages and fed on a standard laboratory pellet 
diet with water supplied ad libitum. All animal procedures 
were approved by Animal Care and Use Committee (ACUC), 
Faculty of Medicine and Health Science, Universiti Putra 
Malaysia (ACUC No: UPM/FPSK/PADS/BR/UUH/F01-
00208). Experimental animals were randomly divided into 
five groups (seven rats in each group). Group I (control 
rats) were given vehicle, 1% carboxymethylcelulose 
(CMC). Group II, III and IV were treated with ethanolic 
extract of F. deltoidea suspended in 1% CMC at doses of 
100, 500 and 1000 mg/kg b.w., respectively. Group V was 
treated with metformin suspended in 1% CMC at the dose 
of 500 mg/kg b.w.
HyPOGLyCEMIC AND POSTPRANDIAL 
ANTIHyPERGLyCEMIC TEST
In hypoglycemic test, rats were fasted 12 h prior to test 
whereas in postprandial antihyperglycemic test, rats were 
fasted 1 h prior to test. After fasting period, the rats were 
given orally with either F. deltoidea ethanolic extract or 
metformin using intragastric gavage. Blood were collected 
from the tail vein just before (0 h) and after 2, 4 and 6 h 
administration of extract or metformin for the measurement 
of blood glucose concentration. 
ORAL GLUCOSE TOLERANCE TEST (OGTT)
For OGTT evaluation, the rats were fasted for 12 h and blood 
was taken 30 min before administration of F. deltoidea or 
metformin. Thirty minutes later, the rats from all groups 
were given glucose (1.5 g/kg) orally. Blood were collected 
from the tail vein just prior to glucose administration 
(0 min), 30, 60, 120 and 180 min after glucose loading. 
Total glyceamic responses to OGTT were calculated from 
respective areas under the glucose curve (AUCGlucose) during 
the 180 min observation period using a computer Calculator 
Software provided by Thomas Wolever from Department 
of Nutritional Sciences, University of Toronto, Toronto, 
Ontario, Canada (Jalil et al. 2008).
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BIOCHEMICAL ANALySIS 
The glucose level was determined by using electronic 
glucometer, Accu Check Advantage from Roche Diagnostic 
(Indianapolis, USA).
STATISTICAL ANALySIS
The results were expressed as mean ± standard deviation 
of seven rats. All data were analysed using one way ANOVA 
and followed by Tukey multiple comparison test. Groups 
mean were considered significantly different at the level 
of p<0.05. 
RESULTS
HyPOGLyCEMIC TEST
Table 1 shows the effect of ethanolic extract of F. deltoidea 
on fasting blood glucose in normal rats. The extract at 
doses of 500 and 1000 mg/kg b.w., significantly reduced 
blood glucose level after 2, 4 and 6 h of administration 
whereas extract at a dose of 100 mg/kg b.w., significantly 
reduced blood glucose level after 6 h of administration 
only. The hypoglycemic effect of the extracts at doses of 
500 and 1000 mg/kg b.w. after 6 h of administration was 
comparable to the metformin group. Among three doses, 
the highest dose which is 1000 mg/kg b.w. seem to be 
the most potent in reducing fasting blood glucose level 
in normal rats. 
POSTPRANDIAL ANTIHyPERGLyCEMIC TEST 
The postprandial antihyperglycemic effects of ethanolic 
extract of F. deltoidea in normal rats are shown in Table 
2. The results showed that extract at 100 and 500 mg/
kg b.w., significantly reduced blood glucose level after 
4 and 6 h of administration whereas at 1000 mg/kg b.w. 
significantly reduced blood glucose level after 2, 4 and 6 
h of administration. The postprandial antihyperglycemic 
effect possess by dose of 1000 mg/kg b.w. was 
comparable to metformin group which significantly 
reduced postprandial hyperglycemia after 2, 4 and 6 h 
of administration. Among the three doses evaluated, 
the highest dose which is 1000 mg/kg b.w. appeared 
to be the most effective dose in reducing postprandial 
hyperglycemia in normal rats. 
TABLE 1. Effect of ethanolic extract of F. deltoidea on fasting blood glucose concentration in normal rats 
Treatment group Blood glucose level (mmol/L)
0 hr 2 hr 4 hr 6 hr
Control 4.93 ± 0.26 4.83 ± 0.48 4.78 ± 0.31 4.83 ± 0.50
F. deltoidea (100 mg/kg) 5.02 ± 0.62 4.65 ± 0.70 4.51 ± 0.67 4.14 ± 0.67
(17.6%) **
F. deltoidea (500 mg/kg) 5.18 ± 0.36 4.43 ± 0.91
(14.5%) *
4.17 ± 0.89
(19.6%) **
3.93 ± 0.68
(24.3%) **
F. deltoidea (1000 mg/kg) 5.18 ± 0.38 3.99 ± 0.64
(22.9%) **
4.29 ± 0.64
(17.3%) **
3.81 ± 0.43
(26.5%) **
Metformin (500mg/kg) 4.43 ± 0.41 4.083 ± 0.61 3.96 ± 0.62 3.28 ± 0.38
(26.1%) **
   
Results were expressed as mean ± standard deviation of seven rats. Values in bracket indicate percentage of blood glucose reduction relative to 0-hour of the 
respective treatment group. *p<0.05 and **p<0.01 compared to 0 hour of the respective group
TABLE 2. Effect of ethanolic extract of F. deltoidea on postprandial glucose concentration in normal rats 
Treatment group Blood glucose level (mmol/L)
0 hr 2 hr 4 hr 6 hr
Control 8.98 ± 0.46 8.37 ± 1.02 8.35 ± 0.99 8.08 ± 1.30
F. deltoidea (100 mg/kg) 8.19 ± 0.38 7.771 ± 0.42 6.81 ± 0.70 
(16.8%) **
6.63 ± 0.25 
(19.1%) **
F. deltoidea (500 mg/kg) 7.83 ± 0.31 7.53 ± 0.47 6.70 ± 0.26 
(14.4%) ** 
6.78 ± 0.59 
(13.4%) **
F. deltoidea (1000 mg/kg) 8.19± 0.66 7.40 ± 0.56 
(10.0%) *
6.70 ± 0.65 
(18.2%) **
6.92 ± 0.38 
(15.5%) **
Metformin (500 mg/kg) 8.20 ± 0.43 7.11 ± 0.63 
(13.3%) **
6.93 ± 0.68 
(15.5%) **
6.52 ± 0.90 
(20.5%) **
Results were expressed as mean ± standard deviation of seven rats. Values in bracket indicate percentage of blood glucose reduction relative to 0-hour of the respective 
treatment group. *p<0.05 and **p<0.01 compared to 0 hour of the respective group
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ORAL GLUCOSE TOLERANCE TEST 
All group of rats showed similar baseline (0 min) of blood 
glucose levels (Table 3). The highest increase in blood 
glucose level in all groups was observed 30 min after 
glucose administration. The changes of blood glucose 
level were 1.75-fold, 1.68-fold, 1.77-fold, 1.76-fold and 
1.17-fold in control group, extract 100 mg/kg b.w., extract 
500 mg/kg b.w., extract 1000 mg/kg b.w. and metformin 
group, respectively as compared to glucose administration 
time (0 minutes) of the respective treatment group. 
 Blood glucose level of groups treated with all doses of 
ethanolic extract was significantly reduced after 120 and 
180 min of glucose administration compared to respective 
time from the control group. Meanwhile, metformin treated 
group showed a significant reduction of blood glucose 
level after 60, 120 and 180 min of glucose administration 
as compared to respective time from the control group 
(Table 3). 
 Areas under the glucose curve (AUCGlucose) for each 
individual rat was calculated to determine the increment 
of blood glucose concentration from 0 to 180 min (Table 
4). Extract at doses of 100, 500 and 1000 mg/kg b.w. 
significantly attenuated AUCGlucose value by 37.39% 
(p<0.01), 32.46% (p<0.05), and 32.45% (p<0.05) as 
compared with control group. However, the attenuation of 
AUCGlucose value by such extracts was less than metformin 
which attenuated AUCGlucose value by 89.11% (p<0.001) 
relative to the control group. Of the three doses evaluated, 
the lowest dose which is 100 mg/kg b.w. was found to be 
most potent in improving glucose tolerance activity in 
normal rats. 
DISCUSSION
F. deltoidea has been used for long time as a traditional 
medicine to counter high blood glucose. However, 
scientific studies to evaluate its efficacy and possible 
mode of action are still lacking. Only two studies on F. 
deltoidea has been done which reports glucose lowering 
effect of aqueous extract of this plant in normal rats 
(Aminudin et al. 2007) and mild diabetic rats (Adam et 
al. 2007). 
 In order to challenge the potential of ethanolic 
extract of F. deltoidea in reducing blood glucose 
concentration, conventional antidiabetic drug, metformin 
was used as positive control. Metformin which belongs 
to biguanides group has been reported to be an effective 
antihyperglycemic agent and the main mechanism is 
through enhancement of glucose uptake into muscle cells 
and reduction of hepatic glucose production, thereby 
reducing circulation glucose concentration (Hawley et 
al. 2002). 
TABLE 3. Effect of ethanolic extract of F. deltoidea on glucose tolerance activity in normal rats 
Treatment 
group
Time (min)
-30 0 30 60 120 180
Control 4.82 ± 0.56 5.08 ± 0.31 8.91 ± 0.76 7.92 ± 1.08 6.01 ± 0.68 5.32 ± 0.68
F. deltoidea 
100 mg/kg
4.78 ± 0.50 4.98 ± 0.74 8.35 ± 1.12 7.53 ± 0.73 3.95 ± 0.68 
(34.28%) **
3.68 ± 0.36 
(30.83%) **
F. deltoidea 
500 mg/kg
4.37 ± 0.57 5.08 ± 0.82 9.00 ± 0.77 7.70 ± 1.33 4.57 ± 0.66 
(23.96%) **
4.30 ± 0.54
(24.81%)*
F. deltoidea 
1000 mg/kg
4.33 ± 0.41 4.58 ± 0.39 8.05 ± 0.73 7.47 ± 1.46 4.03 ± 0.53 
(32.95%) **
4.17 ± 0.45
(21.62%)*
Metformin 
500 mg/kg
4.56 ± 0.48 4.88 ± 0.44 5.74 ± 0.55 
(35.58%)**
5.09 ± 0.55 
(35.73%)**
4.23 ± 0.50 
(29.62%)**
4.04 ± 0.29
(24.06%)*
Results were expressed as mean ± standard deviation of seven rats. Values in bracket indicate percentage of blood glucose reduction relative to respective time of control 
group. *p<0.05 and **p<0.01 compared with respective time of control group.
TABLE 4. Value of area under glucose curve during the oral glucose tolerance test
Treatment group AUCGlucose value (mmol/L) 95% CI (mmol/L)
Control 328.70 ± 115.70 246.0 – 411.4
F. deltoidea (100 mg/kg) 205.8 ± 38.5 (37.39%) ** 17.2 – 241.4
F. deltoidea (500 mg/kg) 222.0 ± 58.5 (32.46%) * 167.9 – 276.1
F deltoidea (1000 mg/kg) 222.1 ± 70.7 (32.435) * 156.7 – 287.6
Metformin (500 mg/kg) 35.8 ± 17.9 (89.11%) *** 20.9 – 50.8
Data were expressed as mean ± standard deviation of seven rats. Values in bracket indicate percentage of AUCGlucose reduction relative to control group. *p<0.05, 
**p<0.01 and ***p<0.001 compared with control group
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 In this study, the evaluation of antihyperglycemia 
of ethanolic extract of F. deltoidea was evaluated in 
different prandial state; fasting, postprandial and post 
glucose loaded state. Hypoglycemic test in fasting state 
was done to evaluate whether the extract has a tendency 
to produce severe hypoglycemia. The test on postprandial 
antihyperglycemia was done to evaluate the potential 
of the extract to challenge postprandial hyperglycemia 
whereas post glucose loaded antihyperglycemia test 
was done to evaluate the potential of extract to improve 
glucose tolerance activity. In the present study, significant 
reduction of blood glucose level by F. deltoidea ethanolic 
extract at different prandial state suggests the presence of 
antihyperglycemic compounds in ethanolic extract of this 
plant. 
 The results from this study showed that, ethanolic 
extract of F. deltoidea at all doses has the ability to 
produce hypoglycemic effect in rats with fasting condition 
particularly after 6 h of administration. The degree of blood 
glucose reduction produced by extract at doses of 500 
and 1000 mg/kg b.w. was comparable to the metformin 
treated group. This result indicates that the extract did not 
produce severe hypoglycemia while reducing fasting blood 
glucose. This is a desirable feature as it has been noted that 
hypoglycemia or low blood sugar level can causes seizures, 
coma, accidents, or death and may even induce permanent 
brain damage (Ryan & Becker 1999). 
 In the evaluation of postprandial antihyperglycemia, 
extract at low and moderate dose, 100 mg/kg b.w. and 
500 mg/kg b.w. significantly reduced blood glucose after 
4 and 6 h of administration whereas the highest dose, 
1000 mg/kg b.w. reduced blood glucose as early as 2 
hours after administration (Table 2). This observation 
indicates that the extract at low dose takes longer time to 
reduce postprandial blood glucose. This is probably due 
to less amount of bioactive constituent(s) present in the 
low dose of extract. Extract at the dose of 1000 mg/kg 
b.w. showed similar potential and trend of postprandial 
antihyperglycemic activity with metformin 500 mg/kg b.w. 
This result suggests that, there is a possibility that ethanolic 
extract mediates postprandial antihyperglycemic activity 
through the similar mechanism as metformin, which 
enhances glucose uptake into muscle cells and reduced 
hepatic gluconeogenesis. 
 In oral glucose tolerance study, all doses of the extract 
significantly attenuated AUCGlucose value compared to the 
control group. This suggests that ethanolic extract of F. 
deltoidea has the ability to improve glucose tolerance 
activity in normal rats. Nevertheless, this activity was 
less effective than metformin as it was shown that, the 
efficiency of metformin in improving glucose tolerance 
activity was greater than ethanolic extract. This observation 
indicates that the glucose tolerance activity produced 
by the extract was not as potent as metformin. This 
could be due to F. deltoidea extracts contain a mixture 
of active and non-active compounds which reduce the 
concentration of active compounds and decrease the 
ability to improve glucose tolerance activity. Therefore, 
to enhance the effectiveness of such extract in improving 
glucose tolerance, further works to be carried out to isolate 
the bioactive compounds from the extract. Among three 
doses that have been evaluated, the lowest dose, 100 mg/
kg b.w. possesses the highest glucose tolerance activity. 
The remaining doses, 500 and 1000 mg/kg b.w. did not 
produced expected higher glucose tolerance activity than 
100 mg/kg. At the higher dose of ethanolic extract, the 
presence of non-bioactive compounds may antagonist or 
interfere the glucose tolerance activity. 
 Numerous plants have been reported to possess 
antihyperglycemic activity such as Aegle marmelos 
(Kesari et al. 2006) and Leandra lacunosa (Cunha et 
al. 2008). These plants mediate such activity through 
various mechanisms such as by stimulating insulin 
release from pancreatic beta cells (Gireesh et al. 2009), 
augmentation of glucose transport into adipocytes and 
muscle (Anandharajan et al. 2005; Jung et al. 2009) or 
combination of both mechanisms (Gray & Flatt 1998), 
reducing glucose production from liver (Hundal et al. 
2000) and delaying glucose absorption from small intestine 
through the inhibition of α-glucosidase enzymes (Coniff & 
Krol 1997; Uebanso et al. 2007). The mechanisms by which 
ethanolic extract mediates the antihyperglycemic activity 
were studied and it was  found that F. deltoidea ethanolic 
extract significantly stimulated insulin secretion from 
pancreatic cell line (unpublished data), enhanced glucose 
uptake by liver (Adam et al. 2009) and peripheral cells 
(unpublished data), and inhibited α-glucosidase enzymes in 
small intestine (Adam et al. 2010). Combinations of these 
mechanisms have partly evidenced the antihyperglycemic 
activity of F. deltoidea ethanolic.
 The control of postprandial hyperglycemia is one of 
the beneficial therapy for management of type II diabetes 
mellitus (Kim et al. 2005) along with nutrition, oral 
hypoglycaemic and insulin therapies (David 2005). In 
addition, controlling postprandial hyperglycemia could 
also prevent the development of macro-and microvascular 
complications associated with diabetes (Baron 1998). 
The use of plants with postprandial antihyperglycemic 
property such as Mucuna pruriens (Bhaskar et al. 2008) 
and Cynara cardunculus (Nomikos et al. 2007) as well as 
plants with glucose tolerance property such as Helicteres 
ixora (Venkatesh et al. 2004) and Tournefortia hartwegiana 
(Ortiz-Andrade et al. 2007) may benefits the diabetic 
patients in controlling postprandial hyperglycemia. Based 
on the results of the present study, it is suggested that F. 
deltoidea could be included as an antihyperglycemic plant 
and may be advantageous to the diabetic patients in the 
controlling of postprandial hyperglycemia. 
CONCLUSIONS
From this study, it has been shown that ethanolic extract of 
F. deltoidea possess postprandial antihyperglycemic and 
glucose tolerance activity in normal rats. In addition, F. 
deltoidea does not cause severe hypoglycemia. Therefore, 
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it is suggested that F. deltoidea can be used as a dietary 
adjunct to counter hyperglycemia and has the potential 
to be developed as new oral antidiabetic agent for the 
treatment of diabetes mellitus. 
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